| Composition | Ursodeoxycholic Acid – 150 mg |
|---|---|
| Dosage | TABLET |
| Packing Size | 10×10 |
| Packing | Blister |
UDICOP-150 is a clinically proven hepatoprotective formulation designed to support liver health and manage gallstone-related conditions. With Ursodeoxycholic Acid 150 mg as its core component, this medicine works by reducing cholesterol saturation in bile and protecting hepatocytes (liver cells) from damage.
Ursodeoxycholic Acid has been widely used in medical practice for the treatment of cholestatic liver diseases, fatty liver, primary biliary cholangitis, and gallbladder dysfunction. Its powerful detoxifying and bile-regulating properties make UDICOP-150 a reliable therapeutic option for maintaining optimal liver performance.
Ursodeoxycholic Acid is a secondary bile acid that occurs naturally in small quantities in the human body. It modifies the composition of bile, making it less toxic and more fluid, thereby improving bile flow and preventing bile stagnation.
In patients with liver or gallbladder diseases, the accumulation of hydrophobic (toxic) bile acids causes inflammation and cellular damage. UDCA replaces these harmful bile acids, thereby reducing toxicity and protecting the liver and bile ducts from further damage.
UDICOP-150 exerts its therapeutic action through multiple mechanisms:
Cholesterol Reduction:
Ursodeoxycholic Acid decreases intestinal absorption and hepatic synthesis of cholesterol. It also reduces cholesterol saturation in bile, aiding in the gradual dissolution of cholesterol gallstones.
Cytoprotective Action:
UDCA stabilizes hepatocyte membranes and protects liver cells from damage caused by toxic bile acids and oxidative stress.
Enhanced Bile Secretion:
It promotes the flow of bile from the liver to the intestine, improving digestion and preventing cholestasis.
Immunomodulatory Effect:
UDCA helps modulate immune responses and reduces inflammation in autoimmune liver diseases like primary biliary cholangitis.
Anti-Apoptotic Effect:
It prevents programmed cell death (apoptosis) of liver cells, promoting overall hepatic regeneration and recovery.
UDICOP-150 (Ursodeoxycholic Acid 150 mg) is recommended for the management and treatment of the following conditions:
Cholesterol Gallstones:
Helps in dissolving small, non-calcified cholesterol gallstones in patients where surgical removal is not indicated.
Primary Biliary Cholangitis (PBC):
Used as a first-line therapy to slow disease progression and improve liver enzyme levels in patients with PBC.
Fatty Liver Disease (NAFLD/NASH):
Supports the reduction of liver fat accumulation and improves hepatic enzyme profiles.
Chronic Liver Diseases:
Provides protective and regenerative support in chronic hepatitis, alcoholic liver disease, and drug-induced hepatotoxicity.
Biliary Reflux Gastritis:
Relieves symptoms of bile reflux into the stomach and esophagus.
Promotes Liver Detoxification:
Helps flush out toxic bile acids and metabolic waste, ensuring a healthy liver environment.
Dissolves Gallstones Naturally:
Gradually breaks down cholesterol gallstones without the need for surgical intervention.
Improves Bile Flow:
Enhances bile secretion and prevents bile stagnation, which is crucial for healthy digestion.
Protects Hepatocytes:
Shields liver cells from chemical, metabolic, and oxidative damage.
Regulates Cholesterol Levels:
Reduces hepatic cholesterol production and absorption, promoting healthy lipid metabolism.
Enhances Liver Function Tests (LFTs):
Regular use under medical supervision helps normalize elevated liver enzyme levels.
UDICOP-150 is generally well-tolerated, but in rare cases, some patients may experience:
Mild diarrhea
Nausea or vomiting
Abdominal discomfort
Skin rash
Elevated liver enzymes (temporary)
Consult your doctor immediately if any adverse reactions persist.
Pregnancy and Lactation: Use only if prescribed by your physician.
Avoid Alcohol Consumption: Alcohol can worsen liver damage and reduce the effectiveness of therapy.
Regular Monitoring: Periodic liver function tests (LFTs) are recommended during long-term therapy.
Drug Interactions: May interact with cholesterol-lowering agents like cholestyramine or cyclosporine — consult your doctor before combining medications.
Pharmaceutical-Grade Ursodeoxycholic Acid (150 mg): Ensures high purity and bioavailability.
Manufactured under GMP and ISO-certified facilities.
Clinically proven efficacy in liver protection and gallstone dissolution.
Backed by extensive clinical research and medical endorsement.
UDICOP-150 provides a safe and effective pathway to restore hepatic balance, improve digestion, and protect overall liver function.
Store below 25°C in a dry place.
Protect from light and moisture.
Keep out of reach of children.
Q1. How long does UDICOP-150 take to dissolve gallstones?
A: It may take 6 months to 2 years depending on the size and type of gallstones. Regular ultrasound monitoring is advised.
Q2. Can I take UDICOP-150 for fatty liver?
A: Yes, it supports liver detoxification and improves liver enzyme balance in fatty liver conditions.
Q3. Is UDICOP-150 safe for long-term use?
A: Yes, when used under medical supervision, UDICOP-150 is safe for prolonged therapy in chronic liver disorders.
UDICOP-150 (Ursodeoxycholic Acid 150 mg) is a clinically trusted hepatoprotective medicine that plays a vital role in maintaining liver health, improving bile flow, and naturally dissolving cholesterol gallstones. Its multifaceted action on cholesterol metabolism, bile secretion, and cellular protection makes it one of the most effective liver-supportive formulations available today.
Regular use of UDICOP-150, as prescribed by a healthcare professional, ensures a healthier liver, improved digestion, and enhanced overall well-being.
